David D. O'Toole - 29 Nov 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: CFO
Signature: David O'Toole
Issuer symbol: RCEL
Transactions as of: 29 Nov 2024
Net transactions value: +$18,298
Form type: 4
Filing time: 05 Dec 2024, 17:00:07 UTC
Previous filing: 03 Jun 2024
Next filing: 22 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award	$6,147	+785	+3.6%	$7.83	22,759	29 Nov 2024	Direct	F1
transaction	RCEL	Common Stock	Purchase	$5,952	+475	+2.1%	$12.53	23,234	05 Dec 2024	Direct
transaction	RCEL	Common Stock	Purchase	$6,200	+500	+2.2%	$12.40	23,734	05 Dec 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period which began on June 1, 2024 and which ended on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 3, 2024 (the purchase date of the offering period).

Content

These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period which began on June 1, 2024 and which ended on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 3, 2024 (the purchase date of the offering period).